Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 32.63
-0.27 (-0.82%)
At close: Feb 13, 2026
SHA:688139 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 255.88 | 366.63 | 406.07 | 600.79 | 845.04 | 380.95 |
Depreciation & Amortization | 109.2 | 109.2 | 103.44 | 64.18 | 50.95 | 22.85 |
Other Amortization | 13.17 | 13.17 | 1.4 | 0.42 | 0.77 | 0.35 |
Loss (Gain) From Sale of Assets | -0.23 | -0.23 | 1.6 | 0.31 | - | -0.43 |
Asset Writedown & Restructuring Costs | 1.86 | 1.86 | 5.31 | 0.45 | 1.85 | 7.05 |
Loss (Gain) From Sale of Investments | -29.26 | -29.26 | -85.09 | -67.71 | -483.48 | -93.79 |
Provision & Write-off of Bad Debts | 16.03 | 16.03 | 5.82 | 1.12 | -3.86 | 1.4 |
Other Operating Activities | 73.72 | -5.71 | -7.05 | 54.28 | 41.39 | 3.25 |
Change in Accounts Receivable | -173.74 | -173.74 | 52.35 | -37.55 | 67.46 | 39.62 |
Change in Inventory | -68.72 | -68.72 | 38.34 | 76.78 | -99.12 | -115.64 |
Change in Accounts Payable | 76.51 | 76.51 | -252.2 | -72 | 124.42 | 476.86 |
Change in Other Net Operating Assets | - | - | - | 3.9 | 53.01 | - |
Operating Cash Flow | 260.34 | 291.67 | 249.26 | 632.43 | 591.8 | 696.62 |
Operating Cash Flow Growth | 33.01% | 17.01% | -60.59% | 6.87% | -15.05% | 148.36% |
Capital Expenditures | -120.08 | -126.7 | -177.18 | -294.24 | -204.69 | -88.99 |
Sale of Property, Plant & Equipment | 0.34 | 0.82 | 1.35 | 0.16 | 20.92 | 0.1 |
Cash Acquisitions | -58.73 | -160.41 | -214.99 | -115.35 | - | -432.21 |
Divestitures | - | - | - | - | 459.68 | 21.53 |
Investment in Securities | -93.64 | -521.03 | 573.19 | 66.02 | -1,827 | 320.4 |
Other Investing Activities | 10.48 | 16.11 | 70.38 | 92.24 | 49.21 | 43.95 |
Investing Cash Flow | -261.63 | -791.22 | 252.76 | -251.17 | -1,501 | -135.22 |
Short-Term Debt Issued | - | 189.52 | 6 | - | - | - |
Total Debt Issued | 199.52 | 189.52 | 6 | - | - | - |
Short-Term Debt Repaid | - | -198.59 | -22.5 | -5 | -25 | -3 |
Long-Term Debt Repaid | - | -4.36 | -5.87 | -1.87 | -1.71 | - |
Total Debt Repaid | -203.45 | -202.95 | -28.37 | -6.87 | -26.71 | -3 |
Net Debt Issued (Repaid) | -3.93 | -13.43 | -22.37 | -6.87 | -26.71 | -3 |
Issuance of Common Stock | - | - | - | 36.89 | - | - |
Repurchase of Common Stock | -40.46 | -40.46 | -1.67 | -98.07 | - | - |
Common Dividends Paid | -147.02 | -163.09 | -142.8 | -162.46 | -120.83 | -57.07 |
Other Financing Activities | -60.97 | -9.86 | -1.46 | 24.27 | 11.52 | -85.08 |
Financing Cash Flow | -252.38 | -226.83 | -168.3 | -206.23 | -136.01 | -145.16 |
Foreign Exchange Rate Adjustments | 5.13 | 4.43 | -8.24 | 8.9 | -1.54 | -1.35 |
Net Cash Flow | -248.54 | -721.94 | 325.48 | 183.92 | -1,047 | 414.89 |
Free Cash Flow | 140.26 | 164.96 | 72.08 | 338.18 | 387.11 | 607.63 |
Free Cash Flow Growth | 158.56% | 128.85% | -78.69% | -12.64% | -36.29% | 442.10% |
Free Cash Flow Margin | 6.20% | 7.22% | 3.16% | 11.81% | 18.21% | 43.34% |
Free Cash Flow Per Share | 0.44 | 0.52 | 0.23 | 1.06 | 1.22 | 1.87 |
Cash Interest Paid | - | - | - | - | - | 0.08 |
Cash Income Tax Paid | 91.18 | 104.17 | 103.09 | 137.86 | 120.93 | 100.99 |
Levered Free Cash Flow | -289.57 | 4.09 | -221.96 | 225.74 | 168.55 | 412.31 |
Unlevered Free Cash Flow | -287.19 | 6.22 | -219.77 | 227.41 | 170.36 | 412.36 |
Change in Working Capital | -180.03 | -180.03 | -182.24 | -21.4 | 139.14 | 374.99 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.